Clinical Trials Browser

Melanoma, Cutaneous Malignant × 90 days × Clear all

Cardiofaciocutaneous syndrome, Legius syndrome, Congenital Bone Marrow Failure Syndromes, Melanoma, Cutaneous Malignant, Chordoma, Fanconi Anemia, Melanoma, Neoplasms, Li-Fraumeni Syndrome, Pulmonary Blastoma, Costello Syndrome

NCT06743126 2026-04-13

SUPRAME

Phase 3 Recruiting

360 enrolled

Dermatologic

Melanoma, Cutaneous Malignant

NCT06388252 2026-02-19

Electrochemotherapy Changes in Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Melanoma Patients

Phase NA Enrolling by invitation

10 enrolled

Dermatologic

Melanoma, Cutaneous Malignant

NCT02775461 2026-02-11

Pancreas Registry and High Risk Registry

Recruiting

1,368 enrolled

DermatologicGastrointestinal

Melanoma, Cutaneous Malignant, Colorectal Neoplasms, Hereditary Nonpolyposis, Pancreatic Cyst, Pancreatic Neoplasms, Pancreatitis, Peutz-Jeghers Syndrome, Pancreatitis, Chronic

NCT05479812 2026-02-09

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

Phase 1 Active not recruiting

150 enrolled

DermatologicGenitourinaryThoracic

Melanoma, Cutaneous Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms

Clinical Trials

Clinical Genetics Branch Eligibility Screening Survey

SUPRAME

Electrochemotherapy Changes in Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Melanoma Patients

Pancreas Registry and High Risk Registry

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors